Synthetic Cannabinoid Testing—Urine Frequently Asked Questions
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Clearing the Smoke on Cannabis: Regular Use and Cognitive Functioning
6 Clearing the Smoke on Cannabis Regular Use and Cognitive Functioning Robert Gabrys, Ph.D., Research and Policy Analyst, CCSA Amy Porath, Ph.D., Director, Research, CCSA Key Points • Regular use refers to weekly or more frequent cannabis use over a period of months to years. Regular cannabis use is associated with mild cognitive difficulties, which are typically not apparent following about one month of abstinence. Heavy (daily) and long-term cannabis use is related to more This is the first in a series of reports noticeable cognitive impairment. that reviews the effects of cannabis • Cannabis use beginning prior to the age of 16 or 17 is one of the strongest use on various aspects of human predictors of cognitive impairment. However, it is unclear which comes functioning and development. This first — whether cognitive impairment leads to early onset cannabis use or report on the effects of chronic whether beginning cannabis use early in life causes a progressive decline in cannabis use on cognitive functioning cognitive abilities. provides an update of a previous report • Regular cannabis use is associated with altered brain structure and function. with new research findings that validate Once again, it is currently unclear whether chronic cannabis exposure and extend our current understanding directly leads to brain changes or whether differences in brain structure of this issue. Other reports in this precede the onset of chronic cannabis use. series address the link between chronic • Individuals with reduced executive function and maladaptive (risky and cannabis use and mental health, the impulsive) decision making are more likely to develop problematic cannabis use and cannabis use disorder. -
Medical Cannabis Q&A
Medical Cannabis Q&A 1. What is medical cannabis? The term “medical cannabis” is used to describe products derived from the whole cannabis plant or its extracts containing a variety of active cannabinoids and terpenes, which patients take for medical reasons, after interacting with and obtaining authorization from their health care practitioner. 2. What are the main active ingredients? The chemical ingredients of cannabis are called cannabinoids. The two main therapeutic ones are: THC:CBD a. Tetrahydrocannabinol (THC) is a partial agonist of CB1 and CB2 receptors. It is psychoactive and produces the euphoric effect. Each cannabis product will contain THC and CBD, however b. Cannabidiol (CBD) has a weak affinity for CB1 and CB2 receptors and appears the THC: CBD ratio will differ to exert its activity by enhancing the positive effects of the body’s endogenous depending on the product. cannabinoids. 3. Why do patients take it? Medical cannabis may be used to alleviate symptoms for a variety of conditions. It has most commonly been used in neuropathic pain and other chronic pain conditions. There is limited, but developing clinical evidence surrounding its safety and efficacy, and it does not currently have an approved Health Canada indication. 4. How do patients take it? Cannabis can be smoked, vaporized, taken orally, sublingually, topically or rectally. Different routes of administration will result in different pharmacokinetic and pharmacodynamic properties of the drug. 5. Is it possible to develop dependence on medical cannabis? Yes, abrupt discontinuation after long-term use may result in withdrawal symptoms. Additionally, chronic use may result in psychological dependence. -
The History of Incense Many and I Mean Many Years Ago, Someone Somewhere (Presumably a Caveman) Needed to Keep the Flame Going in His Fire Pit
The History of Incense Many and I mean many years ago, someone somewhere (presumably a caveman) needed to keep the flame going in his fire pit. So, in quickness he grabbed anything he could. Amongst the sticks, there were various leaves and woodland debris. Hastily, he threw all of his findings into the fire. The aroma that swirled all around him was quickly intoxicating. The earliest form of incense was born. A new sensation was started. Since the beginning of time incense has played a significant role in the human existence. Ever since the beneficial invention of fire, mankind has found that many materials release an odor when burnt, some very pleasing, and others not so much. These aromatic scents often accentuate the senses. Some experts believe that the burning of items such as cedar, berries, roots, and resins gave us our first true incense. Incense relics that are thousands of years old have actually been found all over the world. So, it is pretty safe to bet that incense has been a part of many different cultures for a very long time. It is because of this information that the exact origin of incense cannot be traced. The basics of incense are really quite simple. It is a combination of aromatic elements and a heat source. Incense has always had ties to the religious and medical aspects of various cultures, and still does today. The name Incense is actually derived for the Latin verb incendere, meaning to burn. Incense is believed to be an essential element in any offerings made to the gods. -
Cannabis, Synthetic Cannabinoids, and Psychosis Risk: What the Evidence Says
Cannabis, synthetic cannabinoids, and psychosis risk: What the evidence says Research suggests marijuana may be a ‘component cause’ of psychosis ver the past 50 years, anecdotal reports link- Oing cannabis sativa (marijuana) and psychosis have been steadily accumulating, giving rise to the notion of “cannabis psychosis.” Despite this his- toric connection, marijuana often is regarded as a “soft drug” with few harmful effects. However, this benign view is now being revised, along with mounting re- search demonstrating a clear association between can- nabis and psychosis. In this article, I review evidence on marijuana’s im- pact on the risk of developing psychotic disorders, as well as the potential contributions of “medical” mari- juana and other legally available products containing synthetic cannabinoids to psychosis risk. © IKON IMAGES/CORBIS Cannabis use and psychosis Joseph M. Pierre, MD Cannabis use has a largely deleterious effect on pa- Co-Chief, Schizophrenia Treatment Unit VA West Los Angeles Healthcare Center tients with psychotic disorders, and typically is as- Health Sciences Associate Clinical Professor sociated with relapse, poor treatment adherence, and Department of Psychiatry and Biobehavioral Sciences worsening psychotic symptoms.1,2 There is, however, David Geffen School of Medicine at UCLA Los Angeles, CA evidence that some patients with schizophrenia might benefit from treatment with cannabidiol, 3-5 another constituent of marijuana, as well as delta-9-tetrahydro- cannabinol (Δ-9-THC), the principle psychoactive con- stituent of cannabis.6,7 The acute psychotic potential of cannabis has been demonstrated by studies that documented psychotic symptoms (eg, hallucinations, paranoid delusions, derealization) in a dose-dependent manner among Current Psychiatry healthy volunteers administered Δ-9-THC under ex - Vol. -
) (51) International Patent Classification: Columbia V5G 1G3
) ( (51) International Patent Classification: Columbia V5G 1G3 (CA). PANDEY, Nihar R.; 10209 A 61K 31/4525 (2006.01) C07C 39/23 (2006.01) 128A St, Surrey, British Columbia V3T 3E7 (CA). A61K 31/05 (2006.01) C07D 405/06 (2006.01) (74) Agent: ZIESCHE, Sonia et al.; Gowling WLG (Canada) A61P25/22 (2006.01) LLP, 2300 - 550 Burrard Street, Vancouver, British Colum¬ (21) International Application Number: bia V6C 2B5 (CA). PCT/CA2020/050165 (81) Designated States (unless otherwise indicated, for every (22) International Filing Date: kind of national protection av ailable) . AE, AG, AL, AM, 07 February 2020 (07.02.2020) AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, (25) Filing Language: English DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, (26) Publication Language: English HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, (30) Priority Data: MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, 16/270,389 07 February 2019 (07.02.2019) US OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, (63) Related by continuation (CON) or continuation-in-part SC, SD, SE, SG, SK, SL, ST, SV, SY, TH, TJ, TM, TN, TR, (CIP) to earlier application: TT, TZ, UA, UG, US, UZ, VC, VN, WS, ZA, ZM, ZW. US 16/270,389 (CON) (84) Designated States (unless otherwise indicated, for every Filed on 07 Februaiy 2019 (07.02.2019) kind of regional protection available) . -
Sandalwood Incense Sticks, Nag Champa Incense Sticks
+91-8048763857 Padma Perfumery Works https://www.padmarudraksh7.com/ We are indulged into manufacturing and exporting of Incense Sticks. The incense sticks have a soothing fragrance and are mainly used in the worship of God and other ritual activities. About Us Incorporated in the year of 1954, we, Padma Perfumery Work are counted amongst one of the trusted exporter and manufacture of Perfumed Incense Sticks. In our range we also provide quality assured premium array of Frangipani Incense Sticks, Sandalwood Incense Sticks, Nag Champa Incense Sticks, . The incense gives pleasant and sensory experience and is available in different types of fragrances. Also, their quality touches the remarkable standards as we make them using best quality raw materials. All our work is executed as per the set industrial norms. In addition to, we have years of experience in the domain and today we are capable to deliver bulk quantities of top grade incense products. These products are highly demanded by the construction industries due to their unmatched quality, aromatic fragrance and natural composition. Furthermore, we have built a high-tech infrastructural facility where this ranges of incense sticks are made by using latest machines & finest quality production standards. Similarly, we are acknowledged in the market for our supreme quality incense sticks that also have therapeutic benefits. We appreciate the feedback of our customer’s and apply their thoughts in our business process for the improvement of our facilities. The entire processing of products is done under the guidance of experts by following all the latest market trends. We are backed by a team of well educated professionals that work day.. -
Personal Use Cannabis Rules Special Adopted New Rules: N.J.A.C
NEW JERSEY CANNABIS REGULATORY COMMISSION Personal Use Cannabis Rules Special Adopted New Rules: N.J.A.C. 17:30 Adopted: August 19, 2021 by New Jersey Cannabis Regulatory Commission, Dianna Houenou, Chair. Filed: August 19, 2021 Authority: N.J.S.A. 24:6I-31 et seq. Effective Date: August 19, 2021 Expiration Date: August 19, 2022 This rule may be viewed or downloaded from the Commission’s website at nj.gov/cannabis. These rules are adopted pursuant to N.J.S.A. 24:6I-34(d)1a of the New Jersey Cannabis Regulatory, Enforcement Assistance, and Marketplace Modernization Act, N.J.S.A. 24:6I- 31 et seq., and became effective upon acceptance for filing by the Office of Administrative Law. The specially adopted new rules shall be effective for a period not to exceed one year from the date of filing of the new rules, that is, until August 19, 2022. The Commission has provided this special adoption to the Attorney General, State Treasurer, Commissioner of Health, and Commissioner of Banking and Insurance for a consultation period, after which the Commission anticipates filing a proposal to readopt these rules with amendments reflecting the results of that consultation. In accordance with N.J.S.A. 24:6I-34(d)1b the rules, as readopted, will become effective upon acceptance for filing by the Office of Administrative Law if filed on or before the expiration date of the rules published herein. The adopted amendments will be effective upon publication in the New Jersey Register. Federal Standards Analysis The Cannabis Regulatory, Enforcement Assistance, and Marketplace Modernization Act obliges the Cannabis Regulatory Commission to promulgate rules necessary or proper to enable it to carry out the Commission’s duties, functions, and powers with respect to overseeing the development, regulation, and enforcement of activities associated with the personal use of cannabis pursuant to P.L.2021, c.16. -
Download Brochure
Talismans protect and grant us power; they are private prayers we hold close and whisper to in the dark. We wash them in tears. In times of shadow lo v e t h em , and ash they remind us we are protect them safe and loved, guided and sacred. -------------------- and they will love Talismans Collezione Preziosa is a collection of perfumed extracts worn as fetish and armour. and protect Imbued with spirit, dark and deepest love, you on return, halo and perfumed divinity. like a prayer… Worn on skin, close and intimate, they ward off affliction, mischief and harm. Naples, the City of San Gennaro is the motherlode the fertile genesis of Talismans Collezione Preziosa. A city both sacred and profane where a blood miracle is a miracle of love. Choose your protection. In the ancient shadow of rumbling Vesuvius, From The Fool and Journeyman of the Major Arcana, the earth sleeps and mutters a dream of the sea’s embryonic embrace, darkly in dreams of fire-painted skies and embers. the yearning vastness of a nebulous cosmos Odours of ash, incineration and the miraculous resurrection of holy blood. and portent fill centuries of uncertainty. There is a talisman to protect and love you. Precious talismans are needed Alex Musgrave to protect us now more than ever. (The Silver Fox) for Talismans Supplication and miracles, prayers and incantations for divine scented skin. Odours of confrontation and beauty to comfort our precious souls. Talismans Collezione Preziosa. Perfumes of fate and desire. “Every man is a divinity in disguise, a god playing the fool.” Ralph Waldo Emerson A perfume of divination and tarotology. -
The Iconography, Magic, and Ritual of Egyptian Incense
Studia Antiqua Volume 7 Number 1 Article 8 April 2009 An "Odor of Sanctity": The Iconography, Magic, and Ritual of Egyptian Incense Elliott Wise Follow this and additional works at: https://scholarsarchive.byu.edu/studiaantiqua Part of the History Commons BYU ScholarsArchive Citation Wise, Elliott. "An "Odor of Sanctity": The Iconography, Magic, and Ritual of Egyptian Incense." Studia Antiqua 7, no. 1 (2009). https://scholarsarchive.byu.edu/studiaantiqua/vol7/iss1/8 This Article is brought to you for free and open access by the Journals at BYU ScholarsArchive. It has been accepted for inclusion in Studia Antiqua by an authorized editor of BYU ScholarsArchive. For more information, please contact [email protected], [email protected]. AN “ODOR OF SANCTITY”: THE ICONOGRAPHY, MAGIC, AND RITUAL OF EGYPTIAN INCENSE Elliott Wise ragrance has permeated the land and culture of Egypt for millennia. Early Fgraves dug into the hot sand still contain traces of resin, sweet-smelling lotus flowers blossom along the Nile, Coptic priests swing censers to purify their altars, and modern perfumeries export all over the world.1 The numerous reliefs and papyri depicting fumigation ceremonies attest to the central role incense played in ancient Egypt. Art and ceremonies reverenced it as the embodi- ment of life and an aromatic manifestation of the gods. The pharaohs cultivated incense trees and imported expensive resins from the land of Punt to satisfy the needs of Egypt’s prolific temples and tombs. The rise of Christianity in the first century ce temporarily censored incense, but before long Orthodox clerics began celebrating the liturgy in clouds of fragrant smoke. -
Synthetic Cannabinoids (60 Substances) A) Classical Cannabinoid
Synthetic cannabinoids (60 substances) a) Classical cannabinoid OH H OH H O Common name Chemical name CAS number Molecular Formula HU-210 3-(1,1’-dimethylheptyl)-6aR,7,10,10aR-tetrahydro-1- Synonym: 112830-95-2 C H O hydroxy-6,6-dimethyl-6H-dibenzo[b,d]pyran-9-methanol 25 38 3 11-Hydroxy-Δ-8-THC-DMH b) Nonclassical cannabinoids OH OH R2 R3 R4 R1 CAS Molecular Common name Chemical name R1 R2 R3 R4 number Formula rel-2[(1 S,3 R)-3- hydroxycyclohexyl]- 5- (2- methyloctan- 2- yl) CP-47,497 70434-82-1 C H O CH H H H phenol 21 34 2 3 rel-2[(1 S,3 R)-3- hydroxycyclohexyl]- 5- (2- methylheptan- 2- yl) CP-47,497-C6 - C H O H H H H phenol 20 32 2 CP-47,497-C8 rel-2- [(1 S,3 R)-3- hydroxycyclohexyl]- 5- (2- methylnonan- 2- yl) 70434-92-3 C H O C H H H H Synonym: Cannabicyclohexanol phenol 22 36 2 2 5 CAS Molecular Common name Chemical name R1 R2 R3 R4 number Formula rel-2[(1 S,3 R)-3- hydroxycyclohexyl]- 5- (2- methyldecan- 2- yl) CP-47,497-C9 - C H O C H H H H phenol 23 38 2 3 7 rel-2- ((1 R,2 R,5 R)-5- hydroxy- 2- (3- hydroxypropyl)cyclohexyl)- 3-hydroxy CP-55,940 83003-12-7 C H O CH H H 5-(2- methyloctan- 2- yl)phenol 24 40 3 3 propyl rel-2- [(1 S,3 R)-3- hydroxy-5,5-dimethylcyclohexyl]- 5- (2- Dimethyl CP-47,497-C8 - C H O C H CH CH H methylnonan-2- yl)phenol 24 40 2 2 5 3 3 c) Aminoalkylindoles i) Naphthoylindoles 1' R R3' R2' O N CAS Molecular Common name Chemical name R1’ R2’ R3’ number Formula [1-[(1- methyl- 2- piperidinyl)methyl]- 1 H-indol- 3- yl]- 1- 1-methyl-2- AM-1220 137642-54-7 C H N O H H naphthalenyl-methanone 26 26 2 piperidinyl -
(A-9-THC) Content in Herbal Cannabis Over Time
32 Current Drug Abuse Reviews, 2012, 5, 32-40 Increasing Delta-9-Tetrahydrocannabinol (-9-THC) Content in Herbal Cannabis Over Time: Systematic Review and Meta-Analysis Fidelia Cascini*,1, Carola Aiello2 and GianLuca Di Tanna3 1Istituto di Medicina Legale, Università Cattolica del S. Cuore, largo F. Vito, 1 00168 Roma, Italy 2Department of Informatics and Systemics, University ‘La Sapienza’, 00185 Rome, Italy 3Department of Public Health and Infectious Diseases, University "La Sapienza", 00185, Rome, Italy Abstract: Aim: The objective of this meta-analysis is to assess the data regarding changes in herbal cannabis potency over time (from 1970 to 2009). Methods: Systematic searches of 17 electronic scientific databases identified studies on this topic, within which 21 case series studies satisfied our inclusion criteria of reporting the mean tetrahydrocannabinol (THC) value per number of samples per year. No language, publication date, publication type or status restrictions were imposed. The study selection and data extraction processes were performed independently but uniformly by two authors, included screening, determination of eligibility and inclusion of the eligible studies in the systematic review, and a meta-analysis of the results on THC content in herbal cannabis samples. We considered papers and not monographic scientific publications, rejecting all studies that were not focused on the subject of this review. Results: Meta-analysis by year was performed on 21 studies containing 75 total mean THC observations from 1979 to 2009 using the random effects model. The results revealed much variability between studies. Further, there was a significant correlation between year and mean THC in herbal cannabis. The combined data indicated the correlation between year and mean THC in herbal cannabis, revealing a temporal trend of increasing potency (5% above the mean THC value in the Poisson regression analysis). -
Synthetic Cannabinoids, Forensic & Legal Aspects
Synthetic Cannabinoids, Forensic & Legal Aspects Marilyn A. Huestis, PhD Chief, Chemistry & Drug Metabolism National Institute on Drug Abuse, National Institutes of Health Council of Forensic Medicine Istanbul, Turkey August 18, 2011 Synthetic Cannabinoid Overview Cannabinoid pharmacology Chemistry of synthetic cannabinoids Metabolism of synthetic cannabinoids Controlled drug administration studies Analytical methods for the identification of synthetic cannabinoids in biological & non-biological matrices Current legal status of synthetic cannabinoids Cannabis Mechanisms of Action THC binds to cannabinoid receptors & modulates endogenous cannabinoid & other neurotransmitter systems CB-1 receptors primarily in central nervous & cardiovascular systems CB-2 receptors primarily in immune system Non-CB1, non-CB2 receptors G-protein receptors discovered & cloned in late 1980’s Endogenous cannabinoids include anandamide, 2-AG, virodhamine, N-arachidonyl dopamine (NADA), oleamide, 2-arachidonyl glyceryl ether (noladin ether) & others High CB1 Receptor Density Hypothalamus Appetite, Hormones & Sexual behavior Neocortex High cognitive function & Sensory data Basal Ganglia integration Motor control & planning Hippocampus Memory & Learning Amygdala Anxiety, Emotion & Fear Cerebellum Brain Stem Motor control & Spinal Cord & coordination Vomiting reflex & Pain sensation Cannabinoid Mechanisms of Action Receptor distribution in brain correlates with areas involved in physiological, psychomotor & cognitive effects High density in caudate